• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    MEA Ischemic Heart Disease Market Size

    ID: MRFR/MED/1944-HCR
    60 Pages
    Rahul Gotadki
    September 2025

    Middle-East and Africa Ischemic Heart Disease Market information, by Type (stable angina, unstable angina, myocardial infarction, and Others), Diagnosis (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others), Treatment type (Medications, Surgery, Lifestyle changes, and others) - Forecast to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    MEA Ischemic Heart Disease Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Mea Ischemic Heart Disease Size

    MEA Ischemic Heart Disease Market Growth Projections and Opportunities

    The Middle East and Africa have a lot of people with ischaemic heart disease, which is very bad for business there. For ischemic heart disease to happen, the heart muscle needs more blood than it gets. A lot of people get this condition, which means that more tests, treatments, and ways to keep it from happening are needed. IHD is more common in the Middle East and Africa because their people are getting older and their lives are changing. It gets worse as the population grows and more people have risk factors linked to their lifestyle, like not exercising enough and eating poorly. The market will now work differently. It is becoming more common for people in some parts of Africa and the Middle East to move to towns and adopt western ways of life. People who live in cities tend to change the way they eat, smoke more, and move less. All of these things raise the chance of cardiovascular disease and, by extension, IHD. The IHD market is touched by attempts to teach more people about heart health and make more people aware of it. Care for people with ischemic heart disease has changed because of public health campaigns, educational efforts, and community service programs that help people get diagnosed early, make changes to their lifestyle, and stick with their medical treatments. Better imaging methods and biomarker analysis are two new technologies that are very important to the IHD market. A lot of people in the area want modern testing tools because they help doctors make more accurate diagnoses and find ischemic heart disease early, which is good for patients. How easy it is to get to healthcare services like heart care centers and trained healthcare workers is a big market factor. Access to health care may not be the same everywhere in the Middle East and Africa. This can change how often ischaemic heart disease is found and treated, which in turn can change market trends. Things that the government does to improve heart health have an effect on the IHD market. There are more people with ischemic heart disease and it is harder to treat because of investments in cardiovascular care facilities, public health programs, and laws that support healthy habits. All of these change the way market forces work. As economies grow in some African and Middle Eastern countries, they spend more on health care, which is good for the IHD market. When the economy gets better, healthcare facilities get better, medical tools get easier to get, and heart treatments cost less. All of these things affect market growth. New ways to treat IHD, like drug approaches and invasive heart tools, have an effect on the market. There are more ways to treat ischemic heart disease now that drug studies, stent devices, and minimally invasive methods have come a long way. job changes and protective steps are a big part of what IHD does for a job. In the Middle East and Africa, ischemic heart disease is becoming less widespread and less serious. This is partly because of public health programs that help people who are at risk develop healthy habits, get regular tests, and make changes to their lifestyle. Food and culture in the area have an effect on the rate of IHD. Some traditional ways of eating, like eating a lot of fat or sugar, can make things that put you at risk for heart disease worse. When trying to prevent and treat ischaemic heart disease, it's important to take society and food into account.

    MEA Ischemic Heart Disease Market Size Graph

    Market Summary

    The Middle-East and Africa Ischemic Heart Disease market is projected to grow from 12.5 USD Billion in 2024 to 25 USD Billion by 2035.

    Key Market Trends & Highlights

    Middle-East and Africa Ischemic Heart Disease Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 6.5 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 25 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 12.5 USD Billion, reflecting the current demand for ischemic heart disease treatments.
    • Growing adoption of advanced medical technologies due to increasing prevalence of ischemic heart disease is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.5 (USD Billion)
    2035 Market Size 25 (USD Billion)
    CAGR (2025 - 2035) 6.5%
    Largest Regional Market Share in 2024 -)

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Tesla Inc (US), Meta Platforms Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Market Trends

    The rising prevalence of ischemic heart disease in the Middle-East and Africa underscores the urgent need for enhanced healthcare strategies and interventions to address this growing public health challenge.

    World Health Organization (WHO)

    MEA Ischemic Heart Disease Market Market Drivers

    Growing Aging Population

    The demographic shift towards an aging population in the Middle-East and Africa is a crucial driver for the Global Middle-East and Africa Ischemic Heart Disease Market Industry. Older adults are at a higher risk for developing ischemic heart disease, necessitating increased healthcare services and interventions. As life expectancy rises, the demand for specialized cardiac care is expected to grow. This demographic trend indicates a potential increase in market value, as healthcare systems adapt to meet the needs of an aging population.

    Market Growth Projections

    The Global Middle-East and Africa Ischemic Heart Disease Market Industry is projected to witness substantial growth, with estimates suggesting a market value of 12.5 USD Billion in 2024 and a potential increase to 25 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate (CAGR) of 6.5% from 2025 to 2035. Such projections reflect the increasing demand for innovative treatments and healthcare solutions in response to the rising prevalence of ischemic heart disease in the region.

    Increased Awareness and Education

    Rising awareness and education regarding ischemic heart disease are pivotal in shaping the Global Middle-East and Africa Ischemic Heart Disease Market Industry. Health organizations and NGOs are actively promoting knowledge about risk factors, symptoms, and preventive measures. This heightened awareness encourages individuals to seek medical attention earlier, leading to improved health outcomes. Consequently, the demand for diagnostic and therapeutic solutions is likely to rise, further propelling market growth in the coming years.

    Advancements in Medical Technology

    Technological innovations in the medical field are transforming the Global Middle-East and Africa Ischemic Heart Disease Market Industry. The introduction of advanced diagnostic tools, minimally invasive surgical techniques, and novel therapeutic agents enhances patient outcomes and treatment efficiency. For example, the adoption of telemedicine and remote monitoring systems allows for better management of ischemic heart disease, particularly in remote areas. These advancements not only improve patient care but also stimulate market growth, with projections indicating a market value of 25 USD Billion by 2035.

    Rising Prevalence of Ischemic Heart Disease

    The Global Middle-East and Africa Ischemic Heart Disease Market Industry is experiencing growth due to the increasing prevalence of ischemic heart disease across the region. Factors such as urbanization, sedentary lifestyles, and dietary changes contribute to the rising incidence of this condition. For instance, the World Health Organization indicates that cardiovascular diseases are responsible for a significant portion of mortality in the Middle-East and Africa. This trend suggests a growing demand for effective treatment options and healthcare services, potentially driving the market value to 12.5 USD Billion in 2024.

    Government Initiatives and Healthcare Policies

    Government initiatives aimed at combating ischemic heart disease significantly influence the Global Middle-East and Africa Ischemic Heart Disease Market Industry. Various countries are implementing healthcare policies that focus on prevention, early diagnosis, and treatment of cardiovascular diseases. For instance, public health campaigns promoting healthy lifestyles and regular screenings are becoming more prevalent. These initiatives are likely to enhance awareness and accessibility to healthcare services, thereby driving market growth at a CAGR of 6.5% from 2025 to 2035.

    Market Segment Insights

    Regional Insights

    Key Companies in the MEA Ischemic Heart Disease Market market include

    Industry Developments

    Future Outlook

    MEA Ischemic Heart Disease Market Future Outlook

    The Middle-East and Africa Ischemic Heart Disease Market is projected to grow at a 6.5% CAGR from 2024 to 2035, driven by increasing prevalence, technological advancements, and enhanced healthcare access.

    New opportunities lie in:

    • Invest in telehealth solutions to improve patient monitoring and management.
    • Develop innovative drug delivery systems targeting ischemic heart disease.
    • Expand partnerships with local healthcare providers to enhance service delivery and reach.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment and increased healthcare investments.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2023 1.9 (USD Billion)
    Market Size 2024 2.3 (USD Billion)
    Market Size 2032 4.3 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.7 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Geographies Covered Middle East & Africa
      Key Vendors King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp. (U.S.), AUM Cardiovascular (US), HeartWare (U.S.).
    Key Market Opportunities Joint ventures, strategic alliances, mergers, acquisitions and new product developments
    Key Market Drivers Huge funding in R&D and various initiatives by government

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. 'Table
    2. of Content
    3. Report Prologue
    4. Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
    5. Assumptions
      1. Limitations
      2. Market Structure
      3. Market Segmentation 
    6. Research Methodology
      1. Research Process
      2. Primary
    7. Research
      1. Secondary Research
      2. Market Size Estimation
      3. Forecast
    8. Model
    9. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Mega Trends
      5. Macroeconomic Indicators
    10. Market Factor Analysis
      1. Value Chain Analysis
      2. Porters Five
    11. Forces
      1. Demand & Supply: Gap Analysis
      2. Pricing Analysis
    12. Investment Opportunity Analysis
      1. Merger and Acquisition Landscape
    13. Upcoming trends 
      1. Market trends
        1. Technological trends
        2. Insurance & Regulations
        3. Others
    14. Middle-East
    15. and Africa Ischemic heart Disease Market by Type
    16. Middle-East and Africa
    17. Ischemic heart Disease Market by Diagnosis
    18. Middle-East and Africa Ischemic
    19. heart Disease Market by Treatment type
    20. Middle-East and Africa Ischemic heart
    21. Disease Market by Region    
      1. Introduction
    22. Middle East
      1. UAE
        1. Saudi Arabia
        2. Egypt
        3. Others
      2. Africa'

    Middle-East and Africa Ischemic Heart Disease Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials